Recalls & Warnings July 26, 2014 Marketers of Nopal Cactus Drink Settle FTC Charges of Deceptive Claims TriVita Inc., and marketers of the company's "prickly pear" fruit drink Nopalea have agreed to pay $3.5 million in consumer refunds to settle FTC charges they made deceptive claims that the drink treats health problems ranging from skin conditions to joint pain and respiratory problems
Semaglutide and retatrutide both belong to the class of GLP-1 agonists, but retatrutide is being developed as a triple-receptor agonist, potentially offering more extensive effects on weight loss and metabolic health
Restless sleep
3 Hypertension rarely causes noticeable symptoms, which is why its often called the silent killer
The RNA-binding protein SND1 binds to the 3UTR of HSPA5, destabilizing HSPA5 mRNA, thereby inhibiting GPX4 and promoting ferroptosis in osteoarthritis
The TGA said it first identified the potential association between GLP-1 drugs and NAION in 2024 when a study was published in the Journal of the American Medical Association (JAMA) Ophthalmology